Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: TMVR after AMI | Recovering from COVID-19 | Additional benefits of a healthy diet

News You Need to Know Today
Week in Review: TMVR after AMI | Recovering from COVID-19 | Additional benefits of a healthy diet
Saturday, June 12, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 
READ MORE >

Abbott prepared for influx of new patients in wake of Medtronic’s announcement, FDA’s recommendation

In a recent advisory, the FDA specifically mentioned Abbott's HeartMate 3 LVAD as an effective alternative to Medtronic's HVAD system. 

READ MORE >
A doctor speaking with a patient
Share on Twitter Share on Facebook Share on Linkedin

Abbott prepared for influx of new patients in wake of Medtronic’s announcement, FDA’s recommendation

Share on Twitter Share on Facebook Share on Linkedin
A doctor speaking with a patient
In a recent advisory, the FDA specifically mentioned Abbott's HeartMate 3 LVAD as an effective alternative to Medtronic's HVAD system. 
READ MORE >

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  
READ MORE >

Athletes fully recover from COVID-19 with no long-term heart damage

“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained. 

READ MORE >
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Share on Twitter Share on Facebook Share on Linkedin

Athletes fully recover from COVID-19 with no long-term heart damage

Share on Twitter Share on Facebook Share on Linkedin
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained. 
READ MORE >

Healthier diets can reduce the risk of clonal hematopoiesis, adverse cardiovascular outcomes

The new study, published in JAMA Cardiology, included data from more than 44,000 adults. 

READ MORE >
Fruits vegetableshave been seen as a key component to heart health diets.
Share on Twitter Share on Facebook Share on Linkedin

Healthier diets can reduce the risk of clonal hematopoiesis, adverse cardiovascular outcomes

Share on Twitter Share on Facebook Share on Linkedin
Fruits vegetableshave been seen as a key component to heart health diets.
The new study, published in JAMA Cardiology, included data from more than 44,000 adults. 
READ MORE >

In Case You Missed It

Cardiovascular Subspecialty Clinics: How to Grow Big by Thinking Small

Could the shift from treating a large base of cardiovascular patients proactively to a significantly smaller number reactively be the key to actually growing your healthcare business?

READ MORE >
Growing Tree
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular Subspecialty Clinics: How to Grow Big by Thinking Small

Share on Twitter Share on Facebook Share on Linkedin
Growing Tree
Could the shift from treating a large base of cardiovascular patients proactively to a significantly smaller number reactively be the key to actually growing your healthcare business?
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display
FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data
New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks
TAVR Highlights: Predicting long-term outcomes | SCAI, ACC & STS share a message | Weight loss drug linked to key benefits
TAVR or SAVR? A closer look at those decisions | New Impella 5.5 data | First patient enrolled in massive heart failure trial
Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme